20 S-Hydroxyvitamin D3, Noncalcemic Product of CYP11A1 Action on Vitamin D3, Exhibits Potent Antifibrogenic Activity in Vivo
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
CONTEXT: There is no effective treatment for systemic sclerosis and related fibrosing diseases. Recently the action of CYP11A1 on vitamin D(3) was shown to produce biologically active 20S-hydroxyvitamin D [20(OH)D(3)] and 20,23(OH)(2)D(3), 20,22(OH)(2)D(3), and 17,20,23(OH)(3)D(3). OBJECTIVES: Because 20(OH)D(3) is noncalcemic (nontoxic) in vivo at very high doses, we evaluated its antifibrogenic activities both in vitro and in vivo. Because it is further metabolized by CYP11A1, we also tested preclinical utilities of its hydroxyderivatives, especially 20,23(OH)(2)D(3). DESIGN: Human dermal fibroblasts from scleroderma and normal donors were used to test the efficiency of hydroxyvitamin D derivatives in inhibiting TGF-β1-induced collagen and hyaluronan synthesis and inhibiting cell proliferation. The in vivo activity of 20(OH)D(3) was tested using bleomycin-induced sclerosis in C57BL/6 mice. RESULTS: 20(OH)D(3) and 20,23(OH)(2)D(3) inhibited TGF-β1-induced collagen and hyaluronan synthesis similarly to 1,25(OH)(2)D(3) in cultured human fibroblasts. Also, 20(OH)D(3), 20,23(OH)(2)D(3), and 1,25(OH)(2)D(3) suppressed TGF-β1-induced expression of COL1A2, COL3A1, and hyaluronan synthase-2 mRNA, indicating that they regulate these matrix components at the transcriptional level. 20(OH)D(3), 20,23(OH)(2)D(3), 20,22(OH)(2)D(3), and 17,20,23(OH)(3)D(3) inhibited proliferation of dermal fibroblasts with comparable potency with 1,25(OH)(2)D(3), with 20(OH)D(2) being less active and 1α(OH)D(3) being almost inactive. 20,23(OH)(2)D(3) at 3 μg/kg had no effect on serum Ca(++) or fibroblast growth factor-23 levels and did not cause any noticeable signs of morbidity. 20(OH)D(3) markedly suppressed fibrogenesis in mice given sc bleomycin as demonstrated by total collagen content and hematoxylin and eosin staining of skin biopsies. CONCLUSIONS: 20(OH)D(3) is an excellent candidate for preclinical studies on scleroderma, with other CYP11A1-derived products of its metabolism deserving further testing for antibrogenic activity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, 20(OH)D3 and 20,23(OH)2D3 showed anti-fibrosing effects in vitro, and also in vivo for the former.”
From The role of CYP11A1 in the production of vitamin D metabolites and their role in the regulation of epidermal functions (2014) · cites this paper as [86]
In the citing paper
“20(OH)D3 inhibited bleomycin-induced fibrosis in C57BL/6 mice in vivo at a dose of 3 μg/kg, [86], well within its non-calcemic range”
From The role of CYP11A1 in the production of vitamin D metabolites and their role in the regulation of epidermal functions (2014) · cites this paper as [86]
In the citing paper
“We repeated the calcemic testing of 20(OH)D3, 20,23(OH)2D3 and 20(OH)D2 in mice [59,83,86] and this also showed that these secosteroids lack calcemic effects.”
From The role of CYP11A1 in the production of vitamin D metabolites and their role in the regulation of epidermal functions (2014) · cites this paper as [86]
In the citing paper
“Both 20(OH)D3 and 20,23(OH)2D3 displayed similar anti-fibrotic activities on human dermal fibroblasts from scleroderma or normal donors”
From The role of CYP11A1 in the production of vitamin D metabolites and their role in the regulation of epidermal functions (2014) · cites this paper as [86]
In the citing paper
“This demonstrates an in vivo anti-fibrosing potential for 20(OH)D3.”
From The role of CYP11A1 in the production of vitamin D metabolites and their role in the regulation of epidermal functions (2014) · cites this paper as [86]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Holick, M. F. (2007) · New England Journal of Medicine · doi:10.1056/nejmra070553 · Cited by 13,720
Vitamin D, disease and therapeutic opportunities
Plum, L. A., & DeLuca, H. F. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3318 · Cited by 477
Raghow, R., Postlethwaite, A. E., Keski-Oja, J., Moses, H. L., & Kang, A. H. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112950 · Cited by 464
Self-citationTransforming growth factor β as a therapeutic target in systemic sclerosis
Varga, J., & Pasche, B. (2009) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.26 · Cited by 295
Slominski, A. T., Kim, T., Shehabi, H. Z., Semak, I., Tang, E. K. Y., Nguyen, M. N., Benson, H. A. E., Korik, E., Janjetovic, Z., Chen, J., et al. (2012) · The FASEB Journal · doi:10.1096/fj.12-208975 · Cited by 266
Self-citationThe Complex Role of Vitamin D in Autoimmune Diseases
Szodoray, P., Nakken, B., Gaal, J., Jonsson, R., Szegedi, A., Zold, E., Szegedi, G., Brun, J. G., Gesztelyi, R., Zeher, M., et al. (2008) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2008.02127.x · Cited by 234
Guryev, O., Carvalho, R. A., Usanov, S., Gilep, A., & Estabrook, R. W. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2336107100 · Cited by 170
The cytochrome P450scc system opens an alternate pathway of vitamin D3 metabolism
Slominski, A., Semak, I., Zjawiony, J., Wortsman, J., Li, W., Szczesniewski, A., & Tuckey, R. C. (2005) · The FEBS Journal · doi:10.1111/j.1742-4658.2005.04819.x · Cited by 155
Self-citationVitamin D: newly discovered actions require reconsideration of physiologic requirements
Bikle, D. D. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2010.01.003 · Cited by 152
Slominski, A. T., Janjetovic, Z., Fuller, B. E., Zmijewski, M. A., Tuckey, R. C., Nguyen, M. N., Sweatman, T., Li, W., Zjawiony, J., Miller, D., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009907 · Cited by 149
Self-citation
Cited by
Fibroblasts in fibrosis: novel roles and mediators
Kendall, R. T., & Feghali-Bostwick, C. A. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00123 · Cited by 1,082
Pathogenesis of Systemic Sclerosis
Pattanaik, D., Brown, M., Postlethwaite, B. C., & Postlethwaite, A. E. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00272 · Cited by 405
“20(OH)D3 also suppressed development of dermal fibrosis in the BLM, scleroderma mouse model (413).”
BackgroundSelf-citationKey role of CRF in the skin stress response system
Slominski, A. T., Zmijewski, M. A., Zbytek, B., Tobin, D. J., Theoharides, T. C., & Rivier, J. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1092 · Cited by 400
Self-citationNovel activities of CYP11A1 and their potential physiological significance
Slominski, A. T., Li, W., Kim, T.-K., Semak, I., Wang, J., Zjawiony, J. K., & Tuckey, R. C. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.11.010 · Cited by 292
“Pharmacologically administered 20(OH) D3 shows antifibrotic activities both in vitro [57,117,118] and in vivo in bleomycin induced scleroderma [118].”
Self-citationSlominski, A. T., Kim, T., Takeda, Y., Janjetovic, Z., Brożyna, A. A., Skobowiat, C., Wang, J., Postlethwaite, A., Li, W., Tuckey, R. C., et al. (2014) · The FASEB Journal · doi:10.1096/fj.13-242040 · Cited by 269
“In this study, we document for the first time that novel vitamin D derivatives, including 20(OH)D3 and 20, 23(OH)2D3, act as antagonists of ROR - and ROR - mediated transactivation, which is in addition to their actions as partial agonists on the VDR (37).”
BackgroundInfluentialSelf-citationThe serum vitamin D metabolome: what we know and what is still to discover
Tuckey, R. C., Cheng, C. Y. S., & Slominski, A. T. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2018.09.003 · Cited by 245
Self-citationSlominski, A. T., Kim, T.-K., Li, W., Postlethwaite, A., Tieu, E. W., Tang, E. K. Y., & Tuckey, R. C. (2015) · Scientific Reports · doi:10.1038/srep14875 · Cited by 229
“They show antifibrotic activities, both in vitro 37–39 and in vivo , on bleomycin induced scleroderma 39 and also shows anti-cancer activities that are dependent on the cell-type and lineage 38,40–44 .”
Self-citationIs calcifediol better than cholecalciferol for vitamin D supplementation?
Quesada-Gomez, J. M., & Bouillon, R. (2018) · Osteoporosis International · doi:10.1007/s00198-018-4520-y · Cited by 207
On the role of skin in the regulation of local and systemic steroidogenic activities
Slominski, A. T., Manna, P. R., & Tuckey, R. C. (2015) · Steroids · doi:10.1016/j.steroids.2015.04.006 · Cited by 183
“of the disease [100] and reduces fibrosis in a mouse model of bleomycin-induces skin scleroderma [273].”
Self-citationSlominski, A. T., Kim, T.-K., Li, W., Yi, A.-K., Postlethwaite, A., & Tuckey, R. C. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.10.012 · Cited by 170
Self-citationPhotoprotective Properties of Vitamin D and Lumisterol Hydroxyderivatives
Slominski, A. T., Chaiprasongsuk, A., Janjetović, Z., Kim, T., Stefan, J., Slominski, R. M., Hanumanthu, V. S., Raman, C., Qayyum, S., Song, Y., et al. (2020) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-020-00913-6 · Cited by 155
Self-citationVitamin D receptor regulates TGF-β signalling in systemic sclerosis
Zerr, P., Vollath, S., Palumbo‐Zerr, K., Tomčík, M., Huang, J., Distler, A., Beyer, C., Dees, C., Gela, K., Distler, O., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204378 · Cited by 170
Slominski, A. T., Kim, T.-K., Hobrath, J. V., Oak, A. S. W., Tang, E. K. Y., Tieu, E. W., Li, W., Tuckey, R. C., & Jetten, A. M. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.09.024 · Cited by 143
“20(OH)D3 shows antifibrotic properties both in vitro [87-89] and in an in vivo mouse model of bleomycin induced scleroderma [89].”
BackgroundSelf-citationVitamin D in the skin physiology and pathology.
Piotrowska, A., Wierzbicka, J., & Zmijewski, M. A. (2016) · Acta Biochimica Polonica · doi:10.18388/abp.2015_1104 · Cited by 157
The Impact of Vitamin D on Skin Aging
Bocheva, G., Slominski, R. M., & Slominski, A. T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22169097 · Cited by 121
Self-citationSlominski, A. T., Kim, T.-K., Janjetovic, Z., Brożyna, A. A., Żmijewski, M. A., Xu, H., Sutter, T. R., Tuckey, R. C., Jetten, A. M., & Crossman, D. K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103072 · Cited by 121
“While the identification of the VDR/RXR as the target for 20,23(OH)2D3 is consistent with previously reported functional data and molecular modeling [60,65,69,83], identification of the AhR as its primary target was unexpected and hence it was further analyzed in detail as described below.”
ResultSelf-citationBiological Effects of CYP11A1-Derived Vitamin D and Lumisterol Metabolites in the Skin
Slominski, A. T., Kim, T., Janjetović, Z., Slominski, R. M., Li, W., Jetten, A. M., Indra, A. K., Mason, R. S., & Tuckey, R. C. (2024) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2024.04.022 · Cited by 116
Self-citationSlominski, A. T., Kim, T.-K., Shehabi, H. Z., Tang, E. K. Y., Benson, H. A. E., Semak, I., Lin, Z., Yates, C. R., Wang, J., Li, W., et al. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.12.012 · Cited by 100
“These novel vitamin D3 hydroxy-derivatives are biologically active with a potency defined by the cell lineage (Slominski et al., 2010, 2013c), and are at least as potent as the classical 1,25(OH)2D3 (calcitriol) in skin cells with anti-proliferative, pro-differentiation, anti-cancer and…”
InfluentialSelf-citationThe significance of CYP11A1 expression in skin physiology and pathology
Slominski, R. M., Raman, C., Elmets, C. A., Jetten, A. M., Slominski, A. T., & Tuckey, R. C. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111238 · Cited by 106
Self-citationCytochromes P450 and Skin Cancer: Role of Local Endocrine Pathways
Slominski, A., Zmijewski, M., Semak, I., Zbytek, B., Pisarchik, A., Li, W., Zjawiony, J., & Tuckey, R. (2014) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/18715206113139990308 · Cited by 91
Self-citationBrożyna, A. A., Jóźwicki, W., & Slominski, A. T. (2014) · PubMed · Cited by 91
Self-citationGenetic disorders of Vitamin D biosynthesis and degradation
Miller, W. L. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.04.001 · Cited by 84
Vitamin D Signaling in Psoriasis: Pathogenesis and Therapy
Brożyna, A. A., Slominski, R. M., Nedoszytko, B., Zmijewski, M. A., & Slominski, A. T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158575 · Cited by 98
Self-citationSlominski, A. T., Janjetovic, Z., Kim, T.-K., Wasilewski, P., Rosas, S., Hanna, S., Sayre, R. M., Dowdy, J. C., Li, W., & Tuckey, R. C. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.01.014 · Cited by 77
Self-citationNovel vitamin D photoproducts and their precursors in the skin
Slominski, A., Kim, T.-K., Zmijewski, M. A., Janjetovic, Z., Li, W., Chen, J., Kusniatsova, E. I., Semak, I., Postlethwaite, A., Miller, D. D., et al. (2013) · Dermato-Endocrinology · doi:10.4161/derm.23938 · Cited by 76
Self-citationMalignant Melanoma: An Overview, New Perspectives, and Vitamin D Signaling
Slominski, R. M., Kim, T., Janjetović, Z., Brożyna, A. A., Podgórska, E., Dixon, K. M., Mason, R. S., Tuckey, R. C., Sharma, R., Crossman, D. K., et al. (2024) · Cancers · doi:10.3390/cancers16122262 · Cited by 86
Self-citationCOVID‐19 and Vitamin D: A lesson from the skin
Slominski, R. M., Stefan, J., Athar, M., Holick, M. F., Jetten, A. M., Raman, C., & Slominski, A. T. (2020) · Experimental Dermatology · doi:10.1111/exd.14170 · Cited by 66
Self-citationSlominski, A. T., Kim, T., Slominski, R. M., Song, Y., Janjetović, Z., Podgórska, E., Reddy, S. B., Song, Y., Raman, C., Tang, E. K. Y., et al. (2022) · The FASEB Journal · doi:10.1096/fj.202200578r · Cited by 62
Self-citationFibrosis and the bladder, implications for function ICI‐RS 2017
Fry, C. H., Kitney, D., Panicker, J. N., Drake, M. J., Kanai, A., & Andersson, K. (2018) · Neurourology and Urodynamics · doi:10.1002/nau.23725 · Cited by 65
“Furthermore, vitamin-D3 deficiency is associated with liver fibrosis.(40) Endostatin is a small peptide derived from the carboxy-terminus of collagen type-XVIII and released by fibroblasts.”
BackgroundChen, J., Wang, J., Kim, T., Tieu, E. W., Tang, E. K. Y., Lin, Z., Kovacic, D., Miller, D. D., Postlethwaite, A. E., Tuckey, R. C., et al. (2014) · UWA Profiles and Research Repository (University of Western Australia) · Cited by 62
Self-citationSlominski, A. T., Brożyna, A. A., Zmijewski, M. A., Janjetović, Z., Kim, T., Slominski, R. M., Tuckey, R. C., Mason, R. S., Jetten, A. M., Guroji, P., et al. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-46227-7_13 · Cited by 57
Self-citationNon-Musculoskeletal Benefits of Vitamin D beyond the Musculoskeletal System
Zhang, S., Miller, D. D., & Li, W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042128 · Cited by 68
“Noteworthily, several CYP11A1-derived D3 hydroxymetabolites, such as 20(OH)D3, 20(OH)D2, and 20,23(OH)2D3, lack toxicities and calcemic effects at very high doses (3–60 μg/kg) in mice, in contrast to 1,25(OH)2D3 and 25(OH)D3 [25,30,31].”
BackgroundSelf-citationDifferential antitumor effects of vitamin D analogues on colorectal carcinoma in culture
WIERZBICKA, J. M., BINEK, A., AHRENDS, T., KA, J. D. N., SZYDŁOWSKA, A., TURCZYK, Ł., WĄSIEWICZ, T., WIERZBICKI, P. M., SĄDEJ, R., TUCKEY, R. C., et al. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3088 · Cited by 51
“tissues incubated ex vivo with vitamin D precursors (17,19-21), which are biologically active in cell culture (22) and in vivo (23) models (19,21,24).”
BackgroundSelf-citationVitamin D derivatives enhance cytotoxic effects of H2O2 or cisplatin on human keratinocytes
Piotrowska, A., Wierzbicka, J., Ślebioda, T., Woźniak, M., Tuckey, R. C., Slominski, A. T., & Żmijewski, M. A. (2016) · Steroids · doi:10.1016/j.steroids.2016.04.002 · Cited by 48
“The hydroxyvitamin D3 metabolites produced by these pathways, including the major product, 20(OH)D3, are biologically active in both in vitro (reviewed in [8]) and in vivo [22] models.”
BackgroundSelf-citationChaiprasongsuk, A., Janjetović, Z., Kim, T., Tuckey, R. C., Li, W., Raman, C., Panich, U., & Slominski, A. T. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.05.016 · Cited by 49
Self-citationLin, Z., Marepally, S. R., Goh, E. S. Y., Cheng, C. Y. S., Janjetović, Z., Kim, T., Miller, D. D., Postlethwaite, A. E., Slominski, A. T., Tuckey, R. C., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-19183-7 · Cited by 48
Self-citationLumisterol is metabolized by CYP11A1: discovery of a new pathway
Tuckey, R. C., Slominski, A. T., Cheng, C. Y. S., Chen, J., Kim, T.-K., Xiao, M., & Li, W. (2014) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.08.004 · Cited by 43
“…in a range of cell types cultured in vitro (reviewed in (Slominski et al., 2014a)), and in reducing inflammation and skin fibrosis in mice in vivo (Slominski et al., 2013, 2014a), but lack the toxic and calcemic effects seen with high doses of 1,25(OH)2D3 (Slominski et al., 2010; Wang et al.,…”
BackgroundSelf-citationHydroxylation of CYP11A1-derived products of vitamin D3 metabolism by human and mouse CYP27B1
Tang, E. K. Y., Chen, J., Janjetovic, Z., Tieu, E. W., Slominski, A. T., Li, W., & Tuckey, R. C. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.050955 · Cited by 42
“Importantly in terms of their potential for therapeutic applications, such as in the treatment of scleroderma (Slominski et al., 2013a), it has been shown that, unlike 1,25(OH)2D3, 20(OH)D3 lacks calcemic activity in rodents at doses up to 30 mg/kg, whereas severe hypercalcemia was detected with…”
BackgroundResultSelf-citationJenkinson, C., Desai, R., Slominski, A. T., Tuckey, R. C., Hewison, M., & Handelsman, D. J. (2021) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2021-0441 · Cited by 41
“The major product, 20(OH)D3, has in vivo antifibrogenic [25] and anti-melanoma activities [26].”
BackgroundSelf-citationSlominski, A. T., Brożyna, A. A., Kim, T., Elsayed, M., Janjetović, Z., Qayyum, S., Slominski, R. M., Oak, A. S. W., Li, C., Podgórska, E., et al. (2022) · International Journal of Oncology · doi:10.3892/ijo.2022.5386 · Cited by 41
“While calcemic and other toxic effects place limits on the therapeutic use of 1,25(OH)2D3 or its synthetic derivatives at pharmacological doses, major CYP11A1‐derived vitamin D derivatives are noncalcemic and non‐toxic or show low calcemic effects at supra‐pharmacological doses (37,39,63,64).”
BackgroundSelf-citationDetection of 7-Dehydrocholesterol and Vitamin D3 Derivatives in Honey
Kim, T., Atigadda, V. R., Brzeminski, P., Fabisiak, A., Tang, E. K. Y., Tuckey, R. C., & Slominski, A. T. (2020) · Molecules · doi:10.3390/molecules25112583 · Cited by 36
Self-citationEbrahimpour‐Koujan, S., Sohrabpour, A. A., Giovannucci, E. L., Vatannejad, A., & Esmaillzadeh, A. (2024) · Nutrition Journal · doi:10.1186/s12937-024-00911-x · Cited by 43
“Similarly, calciteriol inhibited TGF-β1-induced collagen type I and III and hyaluronan synthesis in human dermal fibroblast in both in vitro and in vivo situations [34].”
BackgroundBurns, E. M., Elmets, C. A., & Yusuf, N. (2014) · Photochemistry and Photobiology · doi:10.1111/php.12382 · Cited by 41
“Non-calcemic vitamin D analogs have been investigated and have been shown to have antiproliferative, anti-inflammatory, and anti-fibrosing effects (127-129), resulting in a potential area for therapeutic interventions.”
Wierzbicka, J., Zmijewski, M. A., Piotrowska, A., Nedoszytko, B., Lange, M., Tuckey, R. C., & Slominski, A. T. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.08.006 · Cited by 35
“It is well established that CRF and UCN1 enhance expression of POMC trough CRFR1 receptormediated activation of adenylate cyclase (Slominski et al., 2013a).”
BackgroundSelf-citationZabul, P., Woźniak, M., Slominski, A. T., Preis, K., Górska‐Ponikowska, M., Korożan, M., Wieruszewski, J., Zmijewski, M. A., Zabul, E., Tuckey, R. C., et al. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160613043 · Cited by 32
“Moreover, 20(OH)D3 exhibited potent anti-inflammatory [113,114], antifibrogenic [112] and anticancer [110,115] properties, all of which being potentially beneficial in the prevention or therapy of preeclampsia.”
BackgroundSelf-citationNovel CYP11A1-Derived Vitamin D and Lumisterol Biometabolites for the Management of COVID-19
Qayyum, S., Slominski, R. M., Raman, C., & Slominski, A. T. (2022) · Nutrients · doi:10.3390/nu14224779 · Cited by 27
Self-citationTerao, M., Yang, L., Matsumura, S., Yutani, M., Murota, H., & Katayama, I. (2015) · Dermato-Endocrinology · doi:10.1080/19381980.2015.1010983 · Cited by 28
“In that study, metabolites of vitamin D, such as 20S-hydroxyvitamin D, markedly suppressed BLMinduced fibrogenesis in mice.(22) TGFb-induced collagen and hyaluronan production was inhibited by 20(OH)D3 and 1,25 (OH)2D3 in vitro.”
BackgroundVitamin D treatment for connective tissue diseases: hope beyond the hype?
Reynolds, J. A., & Bruce, I. N. (2016) · Rheumatology · doi:10.1093/rheumatology/kew212 · Cited by 33
Antifibrogenic Activities of CYP11A1-derived Vitamin D3-hydroxyderivatives Are Dependent on RORγ
Janjetović, Z., Postlethwaite, A. E., Kang, H. S., Kim, T., Tuckey, R. C., Crossman, D. K., Qayyum, S., Jetten, A. M., & Slominski, A. T. (2020) · Endocrinology · doi:10.1210/endocr/bqaa198 · Cited by 27
Self-citationLin, Z., Marepally, S. R., Ma, D., Myers, L. K., Postlethwaite, A. E., Tuckey, R. C., Cheng, C. Y. S., Kim, T., Yue, J., Slominski, A. T., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00881 · Cited by 25
Self-citationPostlethwaite, A. E., Tuckey, R. C., Kim, T., Li, W., Bhattacharya, S. K., Myers, L. K., Brand, D. D., & Slominski, A. T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.678487 · Cited by 25
“20S(OH)D3 like 1,25(OH)2D3 inhibits collagen synthesis by dermal fibroblasts in vitro, and at a dose of 3 μ/kg in vivo inhibits fibrosis induced by repeated subcutaneous injection of bleomycin into mice (36).”
BackgroundSelf-citationVitamin D3 and its hydroxyderivatives as promising drugs against COVID-19: a computational study
Song, Y., Qayyum, S., Greer, R. A., Slominski, R. M., Raman, C., Slominski, A. T., & Song, Y. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.1964601 · Cited by 26
Self-citationStatus of research on vitamin D supplementation in treating or preventing liver fibrosis
Song, B., & Rockey, D. C. (2013) · Liver International · doi:10.1111/liv.12147 · Cited by 24
Topical vitamin D analogue calcipotriol reduces skin fibrosis in experimental scleroderma
Usategui, A., Criado, G., Rey, M. J. D., Faré, R., & Pablos, J. L. (2014) · Archives of Dermatological Research · doi:10.1007/s00403-014-1466-6 · Cited by 23
“Although multiple open studies in SSc and lSc have been performed, it is unclear whether local or systemic vitamin D therapy may have therapeutic effects in scleroderma A. Usategui G. Criado M. J. Del Rey R. Faré J. L. Pablos (&) Servicio de Reumatologı́a, Instituto de Investigación Hospital 12 de Octubre (i?”
BackgroundInfluentialHolick, M. F., & Slominski, A. T. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91386-7.00006-4 · Cited by 40
Self-citationAlternative pathways for vitamin D metabolism
Slominski, A. T., Tuckey, R. C., Jenkinson, C., Li, W., & Jetten, A. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91386-7.00001-5 · Cited by 25
Self-citationCheng, L., Sun, X., Hu, C., Jin, R., Sun, B., Shi, Y., Cui, W., & Zhang, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113640 · Cited by 23
Lin, Z., Marepally, S. R., Ma, D., Kim, T.-K., Oak, A. S., Myers, L. K., Tuckey, R. C., Slominski, A. T., Miller, D. D., & Li, W. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00182 · Cited by 21
Self-citationHydroxylation of 20-hydroxyvitamin D3 by human CYP3A4
Cheng, C. Y. S., Slominski, A. T., & Tuckey, R. C. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.03.014 · Cited by 20
Self-citationBrzeminski, P., Fabisiak, A., Slominski, R. M., Kim, T., Janjetović, Z., Podgórska, E., Song, Y., Saleem, M., Reddy, S. B., Qayyum, S., et al. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.105660 · Cited by 21
Self-citationMetabolism of 20-hydroxyvitamin D3 and 20,23-dihydroxyvitamin D3 by rat and human CYP24A1
Tieu, E. W., Li, W., Chen, J., Kim, T., Ma, D., Slominski, A. T., & Tuckey, R. C. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.02.010 · Cited by 23
“dermal fibroblasts isolated from scleroderma and normal subjects [26].”
BackgroundSelf-citationLobbins, M. L. B., Scott, I.-S. O., Slominski, A. T., Hasty, K. A., Zhang, S., Miller, D. D., Li, W., Kim, T., Janjetović, Z., Patel, T. S., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168926 · Cited by 18
“5 M acetic acid) overnight at 4 ◦C to remove terminal nonhelical telopeptides and to release collagen into solution as previously described [52].”
MethodSelf-citationMyers, L. K., Winstead, M. L., Kee, J. D., Park, J. J., Zhang, S., Li, W., Yi, A., Stuart, J. M., Rosloniec, E. F., Brand, D. D., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413342 · Cited by 18
Self-citationNarvaez, C. J., Grebenc, D., Balinth, S., & Welsh, J. (2020) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2020.105688 · Cited by 15
“Our data is consistent with published reports that 1,25D and structurally related VDR agonists inhibit TGF-β1-induced HAS2 expression and HA synthesis in cultured human fibroblasts (22).”
ResultInvestigation of Vitamin D2 and Vitamin D3 Hydroxylation by Kutzneria albida
Schmitz, L., Kinner, A., Althoff, K., Rosenthal, K., & Lütz, S. (2021) · ChemBioChem · doi:10.1002/cbic.202100027 · Cited by 17
Vitamin D: A Potential Star for Treating Chronic Pancreatitis
Zheng, M., & Gao, R. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.902639 · Cited by 18
Vitamin D in Systemic Sclerosis: A Review
Perazzi, M., Gallina, E., Manfredi, G. F., Patrucco, F., Acquaviva, A., Colangelo, D., Pirisi, M., & Bellan, M. (2022) · Nutrients · doi:10.3390/nu14193908 · Cited by 17
“Taking together the current body of evidence derived from in vitro studies, consistent data support the hypothesis that vitamin D can modify the fibrogenic activity of fibroblasts, suppressing the pro-fibrotic tissue growth factor (TGF)-β/small mother against decapentaplegic (SMAD) signalling [27,29]; paricalcitol, a…”
ResultTotal synthesis of biologically active 20S-hydroxyvitamin D3
Wang, Q., Lin, Z., Kim, T., Slominski, A. T., Miller, D. D., & Li, W. (2015) · Steroids · doi:10.1016/j.steroids.2015.09.009 · Cited by 15
Self-citationInhibition of HAS2 and hyaluronic acid production by 1,25-Dihydroxyvitamin D3 in breast cancer
Narvaez, C. J., LaPorta, E., Robilotto, S., Liang, J., & Welsh, J. (2020) · Oncotarget · doi:10.18632/oncotarget.27587 · Cited by 17
Dualities of the vitamin D in systemic sclerosis: a systematic literature review
Schneider, L., Hax, V., Monticielo, O. A., Macedo, T. F., Barreto, R. K. M., Marcondes, N. A., & Chakr, R. M. D. S. (2021) · Revista Brasileira de Reumatologia · doi:10.1186/s42358-021-00192-6 · Cited by 14
Metabolism of 20-hydroxyvitamin D3 by mouse liver microsomes
Cheng, C. Y. S., Slominski, A. T., & Tuckey, R. C. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.08.009 · Cited by 13
Self-citationZhang, H., Deng, W., Yang, Y., Wei, S., Xue, L., & Tao, S. (2020) · Toxicology Research · doi:10.1093/toxres/tfaa003 · Cited by 15
Janjetović, Z., Qayyum, S., Reddy, S. B., Podgórska, E., Scott, S. G., Szpotan, J., Mobley, A. A., Li, W., Boda, V. K., Senthilkumar, R., et al. (2024) · Cells · doi:10.3390/cells13030239 · Cited by 12
“In addition, several D3 metabolites have been tested on fibroblasts, including 20(OH)D3 and 20,23(OH) 2 D3, the major products of CYP11A1-mediated vitamin D3 metabolism [17,23,53,54].”
InfluentialSelf-citationDesign, Synthesis and Biological Activities of Novel Gemini 20S-Hydroxyvitamin D3 Analogs.
Lin, Z., Marepally, S. R., Kim, T., Janjetović, Z., Oak, A. S. W., Postlethwaite, A. E., Myers, L. K., Tuckey, R. C., Slominski, A. T., Miller, D. D., et al. (2016) · UWA Profiles and Research Repository (University of Western Australia) · Cited by 9
Self-citationVitamin D endocrine system in breast cancer
Linowiecka, K., Wolnicka-Głubisz, A., & Brożyna, A. A. (2021) · Acta Biochimica Polonica · doi:10.18388/abp.2020_5961 · Cited by 10
“…Lu et al., 2012; Lin et al., 2015; Lin et al., 2016a; Lin et al., 2016b; Lin et al., 2018; Chaiprasongsuk et al., 2019), while the calcemic effects are weaker or are not observed (Slominski et al., 2010; Slominski et al., 2013; Slominski et al., 2014a; Slominski et al., 2014b; Wang et al., 2012).”
BackgroundInfluentialLobbins, M. L. B., Slominski, A. T., Hasty, K. A., Zhang, S., Miller, D. D., Li, W., Kim, T., Janjetović, Z., Tuckey, R. C., Scott, I.-S. O., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010367 · Cited by 9
“We have previously published data showing that noncalcemic analogs of Vit D such as 20-hydroxyvitamin D3 (20-OHD3), a product of CYP11A1 (cytochrome P 450 11A1) action on vitamin D3, exhibited potent antifibrogenic activity in vivo and were effective in the inhibition of bleomycin-induced fibrosis [35].”
BackgroundSelf-citationGenetic Disorders Of Vitamin D Synthesis and Action
Feldman, D., van der Eerden, B. C. J., Malloy, P. J., & Miller, W. L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804182-6.00039-3 · Cited by 10
Xia, Y., Zhao, G., Lin, J., Li, C., Lin, C., Jiang, N., Xu, Q., & Wang, Q. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164717 · Cited by 7
Ewendt, F., Janjetović, Z., Kim, T., Mobley, A. A., Brożyna, A. A., Senthilkumar, R., Fabisiak, A., Brzeminski, P., Siciński, R. R., Stangl, G. I., et al. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00827.2024 · Cited by 6
Self-citationFontes-Dantas, F. L., Cardoso, R. D. C., Domingues, V., & Fernandes, G. G. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-032-04357-3_4 · Cited by 5
Chen, H., Yang, D., Shi, Y., Wu, H., Zhu, H., Jiang, T., Liu, S., & Wang, D. (2024) · Cellular Immunology · doi:10.1016/j.cellimm.2024.104914 · Cited by 3
Nguyen, T. T.-N., Kurokawa, T., Kanemoto, Y., Sawada, T., & Kato, S. (2026) · Biomolecules · doi:10.3390/biom16030396 · Cited by 2
“…2 D 3 , other endogenous molecules can weakly bind VDR—for example, certain bile acids (lithocholic acid) and metabolites like 20-hydroxyvitamin D 3 —but these are much less potent than 1,25(OH) 2 D 3 and are generally considered of minor physiological relevance compared to 1,25(OH) 2 D 3 [44,45].”
Carter, S. E. (2015) · UPT. Syiah Kuala University Library (Syiah Kuala University) · Cited by 2
Rapholo, A. A. F. (2017) · UpSpace Institutional Repository (University of Pretoria)
Ebrahimpour‐Koujan, S., Sohrabpour, A. A., Giovannucci, E. L., Vatannejad, A., & Esmaillzadeh, A. (2024) · Figshare · doi:10.6084/m9.figshare.25303135
Ebrahimpour‐Koujan, S., Sohrabpour, A. A., Giovannucci, E. L., Vatannejad, A., & Esmaillzadeh, A. (2024) · Figshare · doi:10.6084/m9.figshare.26685855
Ebrahimpour‐Koujan, S., Sohrabpour, A. A., Giovannucci, E. L., Vatannejad, A., & Esmaillzadeh, A. (2024) · Figshare · doi:10.6084/m9.figshare.25303007
Schneider, L., Hax, V., Monticielo, O. A., Macedo, T. F., Barreto, R. K. M., Marcondes, N. A., & Chakr, R. M. D. S. (2021) · Figshare · doi:10.6084/m9.figshare.14759597
Etude de la reprogrammation métabolique de l' adénocarcinome canalaire pancréatique
Olivares, O. (2015) · theses.fr (ABES) · doi:10.70675/ef2c6a2czab6dz4a68z8004z1ade8605dadc
Metadata
- Authors
- Slominski, A., Janjetovic, Z., Tuckey, R. C., Nguyen, M. N., Bhattacharya, K. G., Wang, J., Li, W., Jiao, Y., Gu, W., Brown, M., & Postlethwaite, A. E.
- Affiliations
- University of Tennessee Health Science Center (US)
- The University of Western Australia (AU)
- Campbell Clinic (US)
- Corresponding author
- Slominski, Andrzej
- Postlethwaite, Arnold E.
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2013-02
- Volume
- 98
- Issue
- 2
- Pages
- E298-E303
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC3565109
- OpenAlex
- W1972743589
- Cited by
- 89
- References
- 25
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 8 · 2023: 2 · 2022: 7 · 2021: 13 · 2020: 9 · 2018: 5 · 2017: 2 · 2016: 10 · 2015: 12 · 2014: 13 · 2013: 5
- FWCI
- 10.22
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Funders
- National Institutes of Health
- U.S. Public Health Service (R01A052190)
- Health Science Center, University of Tennessee
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR052190, R21AR063242, R01AR056666)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
- Health Sciences › Medicine › Rheumatology › Dupuytren's Contracture and Treatments
- Keywords
- CYP11A1, vitamin D3 metabolism, systemic sclerosis, TGF-β1, collagen synthesis, hyaluronan synthesis, dermal fibroblasts, bleomycin-induced lung fibrosis, 1,25-dihydroxyvitamin D3
- MeSH terms
- Animals, Calcifediol, Cells, Cultured, Collagen, Disease Models, Animal, Fibroblasts, Humans, Hyaluronic Acid, Mice, Inbred C57BL, Scleroderma, Systemic, Skin, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.